Skip to main content

DNA Day Essay Contest!

This is another something that comes across my desk every year, and I LOVE to pass along. You don't have to have Hermansky-Pudlak Syndrome or Chediak-Highashi Syndrome or albinism to enter. Anyone in high school can enter. Good Luck!!!!

Dear Colleague,







The American Society of Human Genetics (ASHG) announces its 7th Annual DNA Day Essay Contest for high school students from across the United States and around the world. You may recall that DNA Day commemorates the anniversary of the publication of Watson and Crick's seminal paper proposing a double-helical structure for DNA.






We have substantially increased the value of the awards for 2012. Students are eligible for cash prizes of $1,000, $600, and $400 for first-, second-, and third-place, respectively, and $100 for honorable mention (10 awards). Teachers of winning students will receive lab equipment grants of equivalent value. We invite you to submit up to six of the best essays your students write. Also, because ASHG has always emphasized the importance of writing quality in the essays, in addition to the accuracy of the genetics content, please consider promoting this contest with your colleagues in the language arts. It is an excellent vehicle for implementing .writing across the curriculum..






Below is a link to the essay question, rules, and deadlines for the 2012 contest. A one-page flyer promoting the contest is also attached. The essay submission site will open in January, and winners will be announced April 20. We know you like to have this information as early in the academic year as possible so that you can build the essay into your teaching plans, and we hope you will be submitting this year.






http://www.ashg.org/education/dnaday.shtml






Best regards,






Michael J. Dougherty, Ph.D.


Director of Education


American Society of Human Genetics






Labels:

Comments

Post a Comment

Popular posts from this blog

Ratner's Cheesecake

Here's another recipe from Toby! Thanks Toby......and I'll get the others posted soon! Ratner's Cheesecake and plain cookies Ratner's was a Jewish dairy restaurant in the lower East Side of Manhattan. This recipe, from my disintegrating, no longer in print Ratner's cookbook, is the closest I've ever gotten to reproducing the rich, heavy cheesecake my mother made when I was a kid. It's worth the time it takes to prepare and every last calorie. Dough Can be prepared in advance. Makes enough for two cakes. Can be frozen or used to make cookies – see recipe below. 1 cup sugar 1 teaspoon vanilla extract 1 cup shortening 1 teaspoon lemon extract 1 cup butter 2 eggs 3 cups sifted cake flour ½ teaspoon salt 2 cups all purpose flour 1 teaspoon baking powder 1. In a bowl, combine all ingredients with hands. Refrigerate 3 -4 hours, or preferably overnight. Filling (for
1 comment
Read more

The next generation with Hermansky-Pudlak Syndrome

I'm so behind on posting about the trip to Puerto Rico. Since the episode of Mystery Diagnosis on Hermansky-Pudlak Syndrome ran right after we got home, it's been a little busy. These, however, are my favorite pictures from Puerto Rico. I know, not pretty senery etc - but these little guys and gals inspire me. They are the next generation of folks with HPS, and if we keep up the hard work, they will live better lives because of it. They motivate me.
Post a Comment
Read more

Some good news about Pirfenidone

Below is a press release from Intermune, the company that makes Pirfenidone. They have essentially reviewed the various clinical trials going on, and decided that Pirfenidone is safe and well tolerated. That would pretty much go along with what we've observed in the HPS community as well. We have a few folks that have been on the drug since the late 90s and continue to do well. Of course, as a journalist, I do have to say consider the source - but at the same time, as someone in a Pirfenidone trial, it's good to know. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting - Analysis shows safety and tolerability of pirfenidone across four clinical trials - VIENNA, Sept. 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that the results of a comprehensive review of safety data from four clinical studies were presented at the 2009 European Respiratory Society Annual Congress in Vienna, Austria
Post a Comment
Read more